Parthasarathy S - Search Results

1

Irbesartan and lipoic acid improve endothelial function and reduce markers of inflammation in the metabolic syndrome: results of the Irbesartan and Lipoic Acid in Endothelial Dysfunction (ISLAND) study.

Sola S, Mir MQ, Cheema FA, Khan-Merchant N, Menon RG, Parthasarathy S, Khan BV. Sola S, et al. Among authors: parthasarathy s. Circulation. 2005 Jan 25;111(3):343-8. doi: 10.1161/01.CIR.0000153272.48711.B9. Epub 2005 Jan 17. Circulation. 2005. PMID: 15655130 Clinical Trial.

2

Irbesartan, an angiotensin type 1 receptor inhibitor, regulates markers of inflammation in patients with premature atherosclerosis.

Navalkar S, Parthasarathy S, Santanam N, Khan BV. Navalkar S, et al. Among authors: parthasarathy s. J Am Coll Cardiol. 2001 Feb;37(2):440-4. doi: 10.1016/s0735-1097(00)01138-4. J Am Coll Cardiol. 2001. PMID: 11216960 Free article.

3

Enhanced solubilization and intestinal absorption of cholesterol by oxidized linoleic acid.

Penumetcha M, Khan-Merchant N, Parthasarathy S. Penumetcha M, et al. Among authors: parthasarathy s. J Lipid Res. 2002 Jun;43(6):895-903. J Lipid Res. 2002. PMID: 12032164 Free article.

4

Effects of eprosartan versus hydrochlorothiazide on markers of vascular oxidation and inflammation and blood pressure (renin-angiotensin system antagonists, oxidation, and inflammation).

Rahman ST, Lauten WB, Khan QA, Navalkar S, Parthasarathy S, Khan BV. Rahman ST, et al. Among authors: parthasarathy s. Am J Cardiol. 2002 Mar 15;89(6):686-90. doi: 10.1016/s0002-9149(01)02340-2. Am J Cardiol. 2002. PMID: 11897210

5

Usefulness of quinapril and irbesartan to improve the anti-inflammatory response of atorvastatin and aspirin in patients with coronary heart disease.

Lauten WB, Khan QA, Rajagopalan S, Lerakis S, Rahman ST, Parthasarathy S, Khan BV. Lauten WB, et al. Among authors: parthasarathy s. Am J Cardiol. 2003 May 1;91(9):1116-9. doi: 10.1016/s0002-9149(03)00161-9. Am J Cardiol. 2003. PMID: 12714159 No abstract available.

6

Irbesartan, an angiotensin type 1 receptor inhibitor, regulates the vascular oxidative state in patients with coronary artery disease.

Khan BV, Navalkar S, Khan QA, Rahman ST, Parthasarathy S. Khan BV, et al. Among authors: parthasarathy s. J Am Coll Cardiol. 2001 Nov 15;38(6):1662-7. doi: 10.1016/s0735-1097(01)01615-1. J Am Coll Cardiol. 2001. PMID: 11704378 Free article. Clinical Trial.

7

Oxidized fatty acids promote atherosclerosis only in the presence of dietary cholesterol in low-density lipoprotein receptor knockout mice.

Khan-Merchant N, Penumetcha M, Meilhac O, Parthasarathy S. Khan-Merchant N, et al. Among authors: parthasarathy s. J Nutr. 2002 Nov;132(11):3256-62. doi: 10.1093/jn/132.11.3256. J Nutr. 2002. PMID: 12421837

8

Did the antioxidant trials fail to validate the oxidation hypothesis?

Parthasarathy S, Khan-Merchant N, Penumetcha M, Khan BV, Santanam N. Parthasarathy S, et al. Curr Atheroscler Rep. 2001 Sep;3(5):392-8. doi: 10.1007/s11883-001-0077-9. Curr Atheroscler Rep. 2001. PMID: 11487450 Review.

9

Oxidative stress in cardiovascular disease.

Parthasarathy S, Khan-Merchant N, Penumetcha M, Santanam N. Parthasarathy S, et al. J Nucl Cardiol. 2001 May-Jun;8(3):379-89. doi: 10.1067/mnc.2001.114150. J Nucl Cardiol. 2001. PMID: 11391309 Review.

10

Lipoic acid effects on established atherosclerosis.

Ying Z, Kherada N, Farrar B, Kampfrath T, Chung Y, Simonetti O, Deiuliis J, Desikan R, Khan B, Villamena F, Sun Q, Parthasarathy S, Rajagopalan S. Ying Z, et al. Among authors: parthasarathy s. Life Sci. 2010 Jan 16;86(3-4):95-102. doi: 10.1016/j.lfs.2009.11.009. Epub 2009 Nov 26. Life Sci. 2010. PMID: 19944706 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

765 results

Search Page